Japanese researchers have identified a new seed of the amyloid beta protein. The discovery could lead to early-stage therapy for the neurodegenerative disease.
According to The Japan Times, Japan scientists have identified clusters of protein believed to trigger Alzheimer’s disease.
The discovery involves a new seed of the amyloid beta protein. Researchers say it could lead to early-stage therapy for the neurodegenerative disease.
The finding was reported on July 21, 2026.
Сообщено ИИ Изображение, созданное ИИ Проверено фактами
Researchers at Yale School of Medicine say they have identified two proteins on the surface of neurons that help shuttle misfolded alpha-synuclein—a key protein implicated in Parkinson’s disease—into healthy cells, a finding that could point to new strategies aimed at slowing progression.
Researchers at the University of California, Riverside have proposed that amyloid beta disrupts tau protein function inside neurons, potentially triggering Alzheimer's disease. The findings challenge the focus on external plaques as the primary cause.
Сообщено ИИ
A major analysis of genetic data has linked 127 gene locations to Alzheimer’s disease, including 48 previously unidentified ones. Researchers also flagged several genes as promising drug targets and highlighted changes in immune and nerve cells.
A cognitive speed-training game that reduces dementia risk appears to boost the brain's clearance of a key protein in men but not women, according to new research presented this week.
Сообщено ИИ
A protein known as SORLA can reduce the toxic effects of tau tangles linked to Alzheimer’s disease. Researchers at Sanford Burnham Prebys showed that higher levels of the protein limited brain atrophy and preserved neuron connections in mice. The findings were published July 17 in Science Advances.